» Articles » PMID: 31446046

Recent Advances in Non-ionic Surfactant Vesicles (niosomes): Fabrication, Characterization, Pharmaceutical and Cosmetic Applications

Overview
Specialty Pharmacology
Date 2019 Aug 26
PMID 31446046
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Development of nanocarriers for drug delivery has received considerable attention due to their potential in achieving targeted delivery to the diseased site while sparing the surrounding healthy tissue. Safe and efficient drug delivery has always been a challenge in medicine. During the last decade, a large amount of interest has been drawn on the fabrication of surfactant-based vesicles to improve drug delivery. Niosomes are self-assembled vesicular nano-carriers formed by hydration of non-ionic surfactant, cholesterol or other amphiphilic molecules that serve as a versatile drug delivery system with a variety of applications ranging from dermal delivery to brain-targeted delivery. A large number of research articles have been published reporting their fabrication methods and applications in pharmaceutical and cosmetic fields. Niosomes have the same advantages as liposomes, such as the ability to incorporate both hydrophilic and lipophilic compounds. Besides, niosomes can be fabricated with simple methods, require less production cost and are stable over an extended period, thus overcoming the major drawbacks of liposomes. This review provides a comprehensive summary of niosomal research to date, it provides a detailed overview of the formulation components, types of niosomes, effects of components on the formation of niosomes, fabrication and purification methods, physical characterization techniques of niosomes, recent applications in pharmaceutical field such as in oral, ocular, topical, pulmonary, parental and transmucosal drug delivery, and cosmetic applications. Finally, limitations and the future outlook for this delivery system have also been discussed.

Citing Articles

Formulation and characterization of BBR loaded niosomes using saponin as a nonionic biosurfactant investigating synergistic effects to enhance antibacterial activity.

Shiri S, Gharanjig K, Tahghighi A, Hosseinnezhad M, Etezad M Sci Rep. 2025; 15(1):5231.

PMID: 39939626 PMC: 11822194. DOI: 10.1038/s41598-025-87950-4.


Innovative Solid Lipid Nanoparticle-Enriched Hydrogels for Enhanced Topical Delivery of L-Glutathione: A Novel Approach to Anti-Ageing.

Liu M, Sharma M, Lu G, Zhang Z, Song W, Wen J Pharmaceutics. 2025; 17(1).

PMID: 39861655 PMC: 11768106. DOI: 10.3390/pharmaceutics17010004.


"Carnosine-Niosomal Delivery System for Targeted Cancer Therapy".

Atta A, Salem M, Reda A, Mohamed T Cell Biochem Biophys. 2024; .

PMID: 39656368 DOI: 10.1007/s12013-024-01626-w.


Advanced Drug Delivery Technologies for Enhancing Bioavailability and Efficacy of Risperidone.

Rathi R, Mehetre N, Goyal S, Singh I, Huanbutta K, Sangnim T Int J Nanomedicine. 2024; 19():12871-12887.

PMID: 39640049 PMC: 11618854. DOI: 10.2147/IJN.S492684.


Nanocarrier-Based Transdermal Drug Delivery Systems for Dermatological Therapy.

Kang Y, Zhang S, Wang G, Yan Z, Wu G, Tang L Pharmaceutics. 2024; 16(11).

PMID: 39598508 PMC: 11597219. DOI: 10.3390/pharmaceutics16111384.